A detailed history of Northwest Bank & Trust CO transactions in Biogen Inc. stock. As of the latest transaction made, Northwest Bank & Trust CO holds 2,821 shares of BIIB stock, worth $490,261. This represents 0.42% of its overall portfolio holdings.

Number of Shares
2,821
Previous 2,830 0.32%
Holding current value
$490,261
Previous $656 Million 16.65%
% of portfolio
0.42%
Previous 0.55%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$189.07 - $236.8 $1,701 - $2,131
-9 Reduced 0.32%
2,821 $547 Million
Q2 2024

Jul 31, 2024

SELL
$190.52 - $236.72 $81,733 - $101,552
-429 Reduced 13.16%
2,830 $656 Million
Q1 2024

May 23, 2024

SELL
$212.02 - $267.71 $2,968 - $3,747
-14 Reduced 0.43%
3,259 $700 Million
Q4 2023

Mar 04, 2024

BUY
$222.59 - $267.94 $3,338 - $4,019
15 Added 0.46%
3,273 $847 Million
Q2 2023

Jul 18, 2023

BUY
$275.25 - $318.06 $896,764 - $1.04 Million
3,258 New
3,258 $928 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Northwest Bank & Trust CO Portfolio

Follow Northwest Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwest Bank & Trust CO with notifications on news.